[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342305-105":59,"doc-detail-342305-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","outcomes-of-the-modern-management-approach-for-locally-advanced-t3t4-laryngeal-cancer-a-retrospective-cohort-study","Outcomes of the modern management approach for locally advanced (T3–T4) laryngeal cancer - a retrospective cohort study","","This retrospective cohort study evaluates survival outcomes in a tertiary head and neck centre (Freeman Hospital, Newcastle upon Tyne NHS Trust) that has favoured primary surgery over chemoradiotherapy for selected locally advanced laryngeal cancer patients, such as those with large-volume tumours, airway compromise, significant dysphagia, and T4 disease. Across 121 T3/T4 patients followed for a mean of 2.9 years, curative-intent disease-specific survival at 2 and 5 years was 77.9% and 64.1%. Future precision medicine research is recommended to define treatment pathways.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/outcomes-of-the-modern-management-approach-for-locally-advanced-t3t4-laryngeal-cancer-a-retrospective-cohort-study/342305/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/outcomes-of-the-modern-management-approach-for-locally-advanced-t3t4-laryngeal-cancer-a-retrospective-cohort-study/342305.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-17","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the study address about advanced laryngeal cancer management?","Question",{"text":113,"@type":114},"The study investigates whether a centre’s surgical management approach for selected T3–T4 patients improves disease-specific survival compared with outcomes reported in the literature.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many patients were included, and what were the T-stage distributions?",{"text":118,"@type":114},"A total of 121 patients were identified: 76 with T3 and 45 with T4 laryngeal cancer.",{"name":120,"@type":111,"acceptedAnswer":121},"What did the study report about disease-specific survival, and how did treatments compare at 2 years?",{"text":122,"@type":114},"Among curative-intent cases, estimated disease-specific survival was 77.9% at 2 years and 64.1% at 5 years. At 2 years, chemoradiotherapy had the highest disease-specific survival (92.5%), followed by surgery with adjuvant therapy (81.8%), radiotherapy alone (75%), and surgery alone (72.4%).",{"name":124,"@type":111,"acceptedAnswer":125},"What does the study conclude and what is recommended for future research?",{"text":126,"@type":114},"The disease-specific survival in the surgical-focused centre appears no higher than that reported in published literature. Future research should focus on precision medicine to define treatment pathways for this disease.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},342305,1790144628,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":34,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","[cambridge.org/jlo](cambridge.org/jlo)  \nMain Article  \nAmarkumar Rajgor takes responsibility for the integrity of the content of the paper  \nCite this article: Rajgor AD, Cowley J, Gillespie C, Lee CW, O’Hara J, Iqbal MS, Hamilton DW. Outcomes of the modern management approach for locally advanced (T3–T4)  \nlaryngeal cancer: a retrospective cohort study. J Laryngol Otol 2024;138:1154–1160. [https://](https://)[ ](https://)[doi.org/10.1017/S0022215124001105](doi.org/10.1017/S0022215124001105)  \nReceived: 5 July 2023  \nRevised: 21 April 2024  \nAccepted: 30 April 2024  \nFirst published online: 21 October 2024  \nKeywords:  \nlarynx; head and neck surgery; chemoradiotherapy; oncology  \nCorresponding author:  \nAmarkumar Rajgor;  \nEmail: [amar. rajgor@newcastle.ac.uk](amar. rajgor@newcastle.ac.uk)  \n© The Author(s), 2024 . Published by Cambridge University Press on behalf of  \nJ.L.O. (1984) LIMITED. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.  \nOutcomes of the modern management approach for locally advanced (T3–T4) laryngeal cancer: a retrospective cohort study  \nAmarkumar Dhirajlal Rajgor1,2 , Josh Cowley3, Colin Gillespie3, Chang Woo Lee2 , James O’ Hara2, Muhammad Shahid Iqbal4  and David Winston Hamilton2  \n1National Institute for Health & Care Research Doctoral Fellow in Otolaryngology, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK, 2Department of Otolaryngology – Head and Neck Surgery, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK, 3School of Mathematics, Newcastle University, Newcastle upon Tyne, UK and 4Department of Clinical Oncology, Northern Centre for Cancer Care, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK  \nAbstract  \nBackground. Our centre (Freeman Hospital, Newcatle Upon Tyne NHS Trust) has favoured primary surgery over chemoradiotherapy for specific advanced laryngeal cancer patients (e.g. large-volume tumours, airway compromise, significant dysphagia, T4 disease) . This study reports the survival outcomes for a modern, high-volume head and neck centre favouring surgical management to determine whether this approach improves survival.  \nMethod. Retrospective analysis of patient data over a seven-year period from a tertiary cancer centre.  \nResults. In total, 121 patients were identified with T3 (n = 76) or T4 (n = 45) laryngeal cancer (mean follow up 2.9 years) . In the cohort treated with curative intent (n = 104, 86.0 per cent), the 2-and 5-year estimated disease-specific survival rates were 77.9 and 64.1 per cent. chemoradiotherapy had the highest 2-year disease-specific survival (92.5 per cent), followed by surgery with adjuvant therapy (81.8 per cent), radiotherapy alone (75 per cent) and surgery alone (72.4 per cent) .  \nConclusion. For a centre favouring primary surgery for certain advanced laryngeal cancers, the disease-specific survival appears no higher than that found in the published literature. To enhance survival, future research should focus on precision medicine to define treatment pathways in this disease.  \nIntroduction  \nSince the 1990s head and neck cancer incidence rates have increased by a third and it is currently the eighth leading form of cancer in the UK.1 A large proportion of these cases occur in the larynx, accounting for 25–30 per cent of all head and neck cancer cases.2 If diagnosed early (stages I–II), disease-specific survival rates range from 70 to 90 per cent, but just under half of all new cases present at an advanced stage (stages III–IV) where, at best, disease-specific survival ranges from 50 to 60 per cent.3–5 Options for definitive treatment in advanced disease include a total laryngectomy (with or without ","cbCaio1iThTCNF3n","https://ap.wps.com/l/cbCaio1iThTCNF3n","pdf",250307,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Introduction\n# Methods\n## Patient population","[{\"question\":\"What question does the study address about advanced laryngeal cancer management?\",\"answer\":\"The study investigates whether a centre’s surgical management approach for selected T3–T4 patients improves disease-specific survival compared with outcomes reported in the literature.\"},{\"question\":\"How many patients were included, and what were the T-stage distributions?\",\"answer\":\"A total of 121 patients were identified: 76 with T3 and 45 with T4 laryngeal cancer.\"},{\"question\":\"What did the study report about disease-specific survival, and how did treatments compare at 2 years?\",\"answer\":\"Among curative-intent cases, estimated disease-specific survival was 77.9% at 2 years and 64.1% at 5 years. At 2 years, chemoradiotherapy had the highest disease-specific survival (92.5%), followed by surgery with adjuvant therapy (81.8%), radiotherapy alone (75%), and surgery alone (72.4%).\"},{\"question\":\"What does the study conclude and what is recommended for future research?\",\"answer\":\"The disease-specific survival in the surgical-focused centre appears no higher than that reported in published literature. Future research should focus on precision medicine to define treatment pathways for this disease.\"}]","Outcomes of the modern management approach for locally advanced (T3–T4) laryngeal cancer - a retrospective cohort study | PDF",1790046068,18,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/160178dfded711d241cd1eb008d4243b.webp",983,1390,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aeddeef0e0a2062ccf7192c9f7c2d79f.webp",982,1388,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d27f4b239d1db14a4307bbe6b794d61b.webp",981,1387,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c07b89834df66ea058eb8f771053ecdd.webp",980,1385]